GC1111

Clinical trials for GC1111 explained in plain language.

Never miss a new study

Get alerted when new GC1111 trials appear

Sign up with your email to follow new studies for GC1111, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hunterase shows continued safety in hunter syndrome patients

Disease control Completed

This study looked at the long-term safety and effectiveness of the drug Hunterase in people with Hunter syndrome. It included 30 patients who had already completed a previous study or had been using Hunterase for at least six months. Researchers monitored lab tests, physical exam…

Matched conditions: GC1111

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

GC1111

Get alerted when new GC1111 trials appear

Hunterase shows continued safety in hunter syndrome patients